« Back to the previous page

Also available in:

Buyer for a clinical CRO in Europe

Company to buy

  • Size: small to mid-sized business
  • Revenue: 3-20 M EUR
  • Location of the target company: Europe. 
  • Reason for acquisition: The company wants a clinical CRO company to expand the company’s operations. 
  • #CFIE PHB095

Overview of the Buyer for a clinical CRO in Europe

This buyer is already operating in Asia and North America and offers non-human primate preclinical research and now is looking for an acquisition in Europe. The company is interested to a clinical CRO company to complements their skills. 

Profile (strategy) of the Buyer for a clinical CRO in Europe

The group is focused in preclinical and clinical pharmacology services for drug discovery, toxicology and early clinical trials in support of small molecules and biologics. The company has offices around the world and with more than 150 employees. The company can provide pharmacokinetic and pharmacodynamic studies and have access to the largest population of non-human primates in Southeast Asia. The company has clients all over the world.

Contact this buyer for a clinical CRO in Europe

Contact us to get details about this Buyer for a clinical CRO in Europe.

Activities and products of this clinical CRO company wanted

The company currently operate in the pre-clinical CRO industry, and are looking at diversifying into clinical & bio-analytical to become a full service CRO solution, looking for specifically for phase 1 trials.

Highlights of buyer for a clinical CRO in Europe

  • AAALAC accredited and OLAW compliant
  • Big range of products
  • Offices the world

Information about this buyer for a clinical CRO in Europe

Feel free to contact us for more information regarding this buyer for a clinical CRO in Europe or if you know possible interested or suited parties. For more buyers for a clinical CRO Europe, please visit the section pharmaceutical companies wanteds. For pharmaceutical manufacturing firm for sale visit the section pharmaceutical pharmaceutical companies for sale.



Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.